comparemela.com

Page 7 - Russian Gamaleya News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Argentine lab strikes deal to produce Russia s Sputnik V

By Eliana Raszewski BUENOS AIRES, Feb 26 (Reuters) - An Argentine laboratory has struck a deal to help produce Russia s COVID-19 vaccine Sputnik V, according to a company statement shared by the country s government on Friday, helping boost the local firm s share price. Laboratorios Richmond has signed a memorandum of understanding with Russia s RDIF sovereign wealth fund to be able to manufacture the vaccine, which has so far been the main drug used in Argentina s fledgling inoculation program. Argentina was one of the first countries in the region to sign an agreement with Russia to buy Sputnik V and has already received 1.22 million doses from the Russian Gamaleya Institute.

AU approves emergency use of AstraZeneca COVID-19 vaccine

AU approves emergency use of AstraZeneca COVID-19 vaccine On Kindly Share This Story: The AU has authorised the AstraZeneca/Oxford coronavirus vaccine for emergency use, the chief of the bloc’s health agency said on Thursday. The Director, Africa Centres for Disease Control and Prevention, Dr John Nkengasong said. “The Africa CDC regulatory task force has now approved the emergency listing of two versions of AstraZeneca vaccines: the Oxford vaccine, that is the one produced in South Korea, and the second in India,” Nkengasong said. The work is now underway to ensure safe vaccination across the region. “We continue to work with countries to support them on safe vaccination administration. Very important training on COVID-19 vaccination by Africa CDC will be starting very, very soon,” Nkengasong added.

Incompetencia total en manejo de vacunas - Diario ExpresoDiario Expreso

Incompetencia total en manejo de vacunas - Diario ExpresoDiario Expreso
expreso.com.pe - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from expreso.com.pe Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.